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IF CHOLECYSTECTOMY increases the
incidence of colonic cancer, as has been
asserted (Capron et al., 1978; Choluj et al.,
1979; Hoare, 1974) the consequences
would be great, inasmuch as 442,000
patients have their gallbladder removed
annually in the United States in non-
federal hospitals alone (Health: United
States, 1978). In point of fact, the colonic
carcinogen 1,2 dimethylhydrazine (DMH)
is one of many carcinogens secreted into
the bile, and bile salts themselves can
be converted to carcinogens such as
3-methylcholanthrene (Chomchai et al.,
1974; Hill, 1974; Laqueur, 1965; Nari-
sawa et al., 1974; Newberne & Rogers,
1973; Preussman et al., 1969; Reddy,
1975; Werner et al., 1977). Moreover,
cholecystectomy in man exposes the gut
to bile continuously rather than inter-
mittently after feeding, and the total bile
salt pool is changed in composition and
size (Pomare & Heaton, 1973) whilst the
24h bile acid output exceeds normal
(Malagelada et al., 1973).
In one experimental study of these
potential relations (Werner et al., 1977)
7000 of mice treated with DMH after
cholecystectomy developed colonic cancer,
compared with 166% in the control un-
operated group. Because of the implica-
tions of this study, we have reinvestigated
the problem, with different results.
Female Swiss mice (Charles River
Breeding Laboratories, Wilmington, Mass.,
40 days old, 20-25 g, n= 63) were divided
into two groups. One group underwent
cholecystectomy under light ether anaes-
thesia; the liver and gallbladder were
exposed in the other group, and a silk
ligature was simply left in the region of
the gallbladder. All animals were dis-
tributed over 4 cages with open wire-
mesh bottoms and had free access to food
and water, while lighting cycles of 12 h
were maintained.
Two weeks after the operation, s.c. in-
jections of 1,2 dimethylhydrazine (DMH)
(Aldrich Chemical Company, Milwaukee,
Wis.) were given (15 mg/kg). This dose of
DMH to female mice regularly produces
colonic neoplasms with minimal liver
damage (Haase et al., 1973; Thurnherr et
al., 1973). Thirty-eight weeks after DMH
treatment, all mice were killed by cervival
dislocation. Their bowels were cleansed by
flushing with isotonic saline solution, and
the whole alimentary tract of each animal
was examined macroscopically. Every
area suspected of neoplastic change was
removed and fixed in 10% formalin.
The x2 test was used to assess the
difference in the proportion of mice with
tumours. Student's t test for unpaired
data was used to analyse the rest of the
results.
There were no statistical differences in
weight. Controls (n= 32) weighed 21.7 +
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be very small and would require many
hundreds of animals for proof.
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